Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neurocrine (NBIX)
NASDAQ:NBIX
Neurocrine (NBIX) Stock Price & Analysis
1,178 Followers
NBIX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$89.04 - $148.37
Previous Close$138.92
Volume615.70K
Average Volume (3M)878.45K
Market Cap
$13.88B
Enterprise Value$13.22B
Total Cash (Recent Filing)$1.03B
Total Debt (Recent Filing)$428.40M
Price to Earnings (P/E)57.2
Beta0.41
Next Earnings
May 01, 2024EPS Estimate
$1.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.43
Shares Outstanding99,507,490
10 Day Avg. Volume848,593
30 Day Avg. Volume878,447
Standard Deviation0.09
R-Squared0.02
Alpha0.00876
Financial Highlights & Ratios
Price to Book (P/B)6.29
Price to Sales (P/S)26.83
Price to Cash Flow (P/CF)28.00
P/FCF Ratio29.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.01
Enterprise Value/Gross Profit7.16
Enterprise Value/Ebitda38.84
Forecast
1Y Price Target
$151.14Price Target Upside8.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering23
Neurocrine News
Ownership Overview
16.31% Insiders
25.87% Mutual Funds
25.89% Other Institutional Investors
31.93% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NBIX FAQ
What was Neurocrine’s price range in the past 12 months?
Neurocrine lowest stock price was $89.04 and its highest was $148.37 in the past 12 months.
What is Neurocrine’s market cap?
Currently, no data Available
When is Neurocrine’s upcoming earnings report date?
Neurocrine’s upcoming earnings report date is May 01, 2024 which is in 14 days.
How were Neurocrine’s earnings last quarter?
Neurocrine released its earnings results on Feb 07, 2024. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.212 by $0.228.
Is Neurocrine overvalued?
According to Wall Street analysts Neurocrine’s price is currently Undervalued.
Does Neurocrine pay dividends?
Neurocrine does not currently pay dividends.
What is Neurocrine’s EPS estimate?
Neurocrine’s EPS estimate is $1.06.
How many shares outstanding does Neurocrine have?
Neurocrine has 99,507,490 shares outstanding.
What happened to Neurocrine’s price movement after its last earnings report?
Neurocrine reported an EPS of $1.44 in its last earnings report, beating expectations of $1.212. Following the earnings report the stock price went down -4.666%.
Which hedge fund is a major shareholder of Neurocrine?
Among the largest hedge funds holding Neurocrine’s share is Dodge & Cox. It holds Neurocrine’s shares valued at 166M.
---
Neurocrine Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$151.14 (8.39% Upside)
$151.14 (8.39% Upside)
Blogger Sentiment
Bullish
NBIX Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 220.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $200.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.8%
Last 30 Days ▲ 8.2%
Last 30 Days ▲ 8.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
33.09%
12-Months-Change
Fundamentals
Return on Equity
12.68%
Trailing 12-Months
Asset Growth
38.66%
Trailing 12-Months
Company Description
Neurocrine
Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.
---
NBIX Earnings Call
Q4 2024
0:00 / 0:00
---
NBIX Stock 12 Months Forecast
Average Price Target
$151.14
▲(8.39% Upside)
Technical Analysis
Best Analysts Covering NBIX
1 Year
1 Year Success Rate
16/18 ratings generated profit
1 Year Average Return
+16.64%
reiterated a buy rating 2 months ago
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +16.64% per trade.
---